Mol Biochem Parasitol. 2026 Oct 30. pii: S0166-6851(26)00069-1. [Epub ahead of print]
111790
BACKGROUND AND AIM: Toxoplasma gondii relies predominantly on purine salvage pathways for intracellular survival due to the absence of complete de novo purine biosynthesis. Targeting parasite purine-associated metabolism, therefore, represents a promising therapeutic strategy for toxoplasmosis.
METHODS: An integrated computational and experimental workflow was employed to identify candidate inhibitors targeting T. gondii adenosine kinase (AK). High-throughput virtual screening of the ChemBridge library was performed, followed by molecular docking, 100ns molecular dynamics simulations, and MM/PBSA binding free energy analysis. Biological evaluation included RH-2F β-galactosidase proliferation assays, purine rescue experiments, intracellular ATP depletion assays, DCFDA-based ROS quantification, and JC-1 mitochondrial membrane potential analysis in infected HFF monolayers.
RESULTS: TAK0104 demonstrated favorable binding within the ACP-defined catalytic cavity of adenosine kinase with a docking score of -8.73kcal/mol and stable ligand retention during a 100ns molecular dynamics simulation. Biologically, TAK0104 inhibited intracellular tachyzoite proliferation with an IC50 of 322.6nM and exhibited comparatively low host-cell toxicity (TD50 = 10,701nM; therapeutic index = 33.2). Purine rescue experiments demonstrated that TAK0104-mediated growth inhibition reduced parasite proliferation to 23.4 ± 4.09% relative to untreated infected controls, whereas hypoxanthine supplementation restored proliferation to 80.8 ± 8.50%. TAK0104 further induced concentration-dependent ATP depletion, intracellular ROS accumulation, and mitochondrial membrane depolarization in infected host-cell cultures, indicating substantial metabolic stress associated with treatment.
CONCLUSIONS: TAK0104 demonstrated potent anti-Toxoplasma activity associated with disruption of parasite purine metabolism, accompanied by energetic, oxidative, and mitochondrial stress responses. Conclusions TAK0104 demonstrated potent anti-Toxoplasma gondii activity, accompanied by changes consistent with purine-associated metabolic disruption, ATP depletion, oxidative stress, and mitochondrial dysfunction in infected host-cell cultures. Although computational analyses support a potential interaction between TAK0104 and T. gondii adenosine kinase (TgAK), the current findings do not establish that direct TgAK inhibition causes the observed antiparasitic activity, and potential host-cell-mediated effects cannot be excluded. Further mechanistic validation is required to establish the contribution of TgAK to TAK0104 activity.
Keywords: Adenosine kinase; Metabolic stress Molecular docking; Purine metabolism; Toxoplasma gondii